These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 38498252)
21. Predictors of Colorectal Cancer Screening: Does Rurality Play a Role? Ojinnaka CO; Choi Y; Kum HC; Bolin JN J Rural Health; 2015; 31(3):254-68. PubMed ID: 25599819 [TBL] [Abstract][Full Text] [Related]
22. Determinants of racial/ethnic colorectal cancer screening disparities. Jerant AF; Fenton JJ; Franks P Arch Intern Med; 2008 Jun; 168(12):1317-24. PubMed ID: 18574089 [TBL] [Abstract][Full Text] [Related]
23. Neighborhood disadvantage and racial disparities in colorectal cancer incidence: a population-based study in Louisiana. Danos DM; Ferguson TF; Simonsen NR; Leonardi C; Yu Q; Wu XC; Scribner RA Ann Epidemiol; 2018 May; 28(5):316-321.e2. PubMed ID: 29678311 [TBL] [Abstract][Full Text] [Related]
24. Race, Poverty, and Mental Health Drive Colorectal Cancer Screening Disparities in the Veterans Health Administration. May FP; Yano EM; Provenzale D; Steers WN; Washington DL Med Care; 2019 Oct; 57(10):773-780. PubMed ID: 31415338 [TBL] [Abstract][Full Text] [Related]
25. Screening prevalence and incidence of colorectal cancer among American Indian/Alaskan natives in the Indian Health Service. Day LW; Espey DK; Madden E; Segal M; Terdiman JP Dig Dis Sci; 2011 Jul; 56(7):2104-13. PubMed ID: 21234688 [TBL] [Abstract][Full Text] [Related]
26. Elevated colorectal cancer incidence among American Indian/Alaska Native persons in Alaska compared to other populations worldwide. Haverkamp D; Redwood D; Roik E; Vindigni S; Thomas T Int J Circumpolar Health; 2023 Dec; 82(1):2184749. PubMed ID: 36867106 [TBL] [Abstract][Full Text] [Related]
27. American Indian/Alaska native access to colorectal cancer screening: Does gastroenterologist density matter? Gutnik L; Bleicher J; Davis A; McLeod MC; McCrum M; Scaife C Am J Surg; 2022 Sep; 224(3):965-970. PubMed ID: 35513914 [TBL] [Abstract][Full Text] [Related]
28. Distrust in health care and cultural factors are associated with uptake of colorectal cancer screening in Hispanic and Asian Americans. Hong YR; Tauscher J; Cardel M Cancer; 2018 Jan; 124(2):335-345. PubMed ID: 28976535 [TBL] [Abstract][Full Text] [Related]
29. Prevalence and predictors of colorectal cancer screening in the United States: evidence from the HINTS database 2018 to 2020. Atarere J; Haas C; Akhiwu T; Delungahawatta T; Pokharel A; Adewunmi C; Annor E; Orhurhu V; Barrow J Cancer Causes Control; 2024 Feb; 35(2):335-345. PubMed ID: 37737304 [TBL] [Abstract][Full Text] [Related]
30. Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study. Schumacher MC; Slattery ML; Lanier AP; Ma KN; Edwards S; Ferucci ED; Tom-Orme L Cancer Causes Control; 2008 Sep; 19(7):725-37. PubMed ID: 18307048 [TBL] [Abstract][Full Text] [Related]
31. Neighborhood Satisfaction and Colorectal Cancer Screening in a Community Sample of African Americans. Halbert CH; Melvin C; Briggs V; Delmoor E; Rice LJ; Lynch C; Jefferson M; Johnson JC J Community Health; 2016 Feb; 41(1):38-45. PubMed ID: 26184107 [TBL] [Abstract][Full Text] [Related]
32. Geographical Disparities in Colorectal Cancer in Canada: A Review. Rouhafzay A; Yousefi J Curr Oncol Rep; 2024 Oct; 26(10):1249-1257. PubMed ID: 39073526 [TBL] [Abstract][Full Text] [Related]
33. Multilevel predictors of colorectal cancer screening use in California. Shariff-Marco S; Breen N; Stinchcomb DG; Klabunde CN Am J Manag Care; 2013; 19(3):205-16. PubMed ID: 23544762 [TBL] [Abstract][Full Text] [Related]
34. How can we boost colorectal and hepatocellular cancer screening among underserved populations? Goebel M; Singal AG; Nodora J; Castañeda SF; Martinez E; Doubeni C; Laiyemo A; Gupta S Curr Gastroenterol Rep; 2015 Jun; 17(6):22. PubMed ID: 26031831 [TBL] [Abstract][Full Text] [Related]
36. Enhancing the use and quality of colorectal cancer screening. Holden DJ; Harris R; Porterfield DS; Jonas DE; Morgan LC; Reuland D; Gilchrist M; Viswanathan M; Lohr KN; Lyda-McDonald B Evid Rep Technol Assess (Full Rep); 2010 Feb; (190):1-195, v. PubMed ID: 20726624 [TBL] [Abstract][Full Text] [Related]
37. Geographic and population-level disparities in colorectal cancer testing: A multilevel analysis of Medicaid and commercial claims data. Davis MM; Renfro S; Pham R; Hassmiller Lich K; Shannon J; Coronado GD; Wheeler SB Prev Med; 2017 Aug; 101():44-52. PubMed ID: 28506715 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of Colorectal Cancer Screening Among Hispanic Subgroups in the United States: NHIS 2010 and 2015 Data. Calderón-Mora J; Alvarado L; Dwivedi A; Shokar N Hisp Health Care Int; 2022 Sep; 20(3):202-211. PubMed ID: 34904453 [No Abstract] [Full Text] [Related]
39. Colorectal Cancer: An Emphasis on Factors Influencing Racial/Ethnic Disparities. Sharma I; Kim S; Sridhar S; Basha R Crit Rev Oncog; 2020; 25(2):151-160. PubMed ID: 33389864 [TBL] [Abstract][Full Text] [Related]
40. Sociocultural and health correlates related to colorectal cancer screening adherence among urban African Americans. Brittain K; Murphy VP Cancer Nurs; 2015; 38(2):118-24. PubMed ID: 24836955 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]